Skip to main content
SpringerLink
Log in

Potassium Channel Openers

Pharmacological Effects and Future Uses

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Allen SL, Boyle JP, Cortijo J, Foster RW, Morgan GP, et al. Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. British Journal of Pharmacology 89: 395–405, 1986

    Article  PubMed  CAS  Google Scholar 

  • Alzheimer C, ten Bruggencate G. Actions of BRL34915 (cromak-alim) upon convulsive discharges in guinea-pig hippocampal slices. Naunyn-Schmiedeberg’s Archives of Pharmacology 337: 429–434, 1988

    Article  PubMed  CAS  Google Scholar 

  • Angersbach D, Nicholson CD. Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease. Naunyn-Schmiedeberg’s Archives of Pharmacology 337: 431–436, 1988

    Article  Google Scholar 

  • Aono J, Akima M, Sakai K. Effects of N-(2-hydroxyethyl) nico-tinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anaesthetised rats. Japansese Journal of Pharmacology 31: 823–830, 1981

    Article  CAS  Google Scholar 

  • Baird A, Hamilton TC, Richards DH, Tasker T, Williams AJ. Inhibition of histamine-induced bronchoconstriction in normal healthy volunteers by a potassium channel activator cromakalim. British Journal of Clinical Pharmacology (Proceedings Suppl.) 25: 114P, 1988

    Google Scholar 

  • Belz GG, Matthews J, Heinrich J, Wagner G. Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man. European Journal of Clinical Pharmacology 26: 681–685, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bidard J-N, Gandolfo G, Mourre C, Gottesmann C, Lazdunski M. The brain response to the bee venom peptide MCD. Activation and desensitization of a hippocampal target. Brain Research 418: 235–244, 1987

    Article  PubMed  CAS  Google Scholar 

  • Buckle DR, Bumstead J, Clarke GD, Taylor JF, Taylor SG. Reversal of agonist-induced bronchoconstriction in the guineapig by the potassium channel activator BRL34915. British Journal of Pharmacology (Proceedings Suppl.) 92: 744P, 1987

    Google Scholar 

  • Callaghan JT, Goldberg MR, Brunelle R. Double-blind comparator trials with pinacidil, a potassium channel opener. Drugs 36 (Suppl. 7): 77–82, 1988

    Article  PubMed  Google Scholar 

  • Carlsen JE, Kardel T, Hilden T, Tango M, Trap-Jensen J. Immediate central and peripheral haemodynamic effects of a new vasodilating agent pinacidil (P1134) in hypertensive man. Clinical Physiology 1: 375–384, 1981

    Article  PubMed  CAS  Google Scholar 

  • Carlsen JE, Kardel T, Jensen HE, Tango M, Trap-Jensen J. Pinacidil a new vasodilator: pharmacokinetics of a new retarded release tablet in essential hypertension. European Journal of Clinical Pharmacology 25: 557–561, 1983

    Article  PubMed  CAS  Google Scholar 

  • Carlsen JE, Kardel T, Lund JO, McNair A, Trap-Jensen J. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension. Clinical Pharmacology and Therapeutics 37: 253–259, 1985

    Article  PubMed  CAS  Google Scholar 

  • Cherubini E, Ben-Ari Y, Gho M, Bidard J-N, Lazdunski M. Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide. Nature (London) 328: 70–73, 1987

    Article  CAS  Google Scholar 

  • Eckl KM, Greb WH. Potassium channel activation in the smooth muscle cell membrane — a new mechanism of action in antihypertensive treatment — early clinical results with BRL34915. Clinical and Experimental Therapeutics 49: 160, 1987

    Google Scholar 

  • Edwards G, Weston AH. Potassium channel openers and vascular smooth muscle relaxation. Pharmacology and Therapeutics, in press, 1990

  • Edwards G, Weston AH. Potassium channel openers: their development and prospects. Current Cardiovascular Patents 1: 1810–1823, 1989

    Google Scholar 

  • Foster CD, Speakman MJ, Fujii K, Brading AF. The effects of cromakatim on the detrusor muscle of human and pig urinary bladder. Journal of Urology 63: 284–294, 1989

    Article  CAS  Google Scholar 

  • Fox JS, Whitehead E, Shanks RG. Cardiovascular effects of the novel antihypertensive agent BRL34915 in normal volunteers. British Journal of Clinical Pharmacology (Proceedings Suppl.) 23: 600P, 1987

    Google Scholar 

  • Friedel HA, Brogden RN. Pinacidil: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 39: 929–967, 1990

    Article  PubMed  CAS  Google Scholar 

  • Fujii K. An electrophysiological investigation of the mechanism of action of BRL34915 on the guinea-pig bladder. British Journal of Pharmacology (Proceedings Suppl.) 92: 750P, 1987

    Google Scholar 

  • Gandolfo G, Gottesmann C, Bidard J-N, Lazdunski M. K+ channel openers prevent epilepsy induced by the bee venom peptide MCD. European Journal of Pharmacology 159: 329–330, 1989a

    Article  PubMed  CAS  Google Scholar 

  • Gandolfo G, Romettino S, Gottesmann C, van Luijtelaar G, Coenen A, et al. K+ channel openers decrease seizures in genetically epileptic rats. European Journal of Pharmacology 167: 181–183, 1989b

    Article  PubMed  CAS  Google Scholar 

  • Garrino MG, Plant TD, Henquin JC. Effects of putative activators in K+-channels in mouse pancreatic β-cells. British Journal of Pharmacology 98: 957–965, 1989

    Article  PubMed  CAS  Google Scholar 

  • Gluck Z, Windenann P, Gnadinger MP, Weidmann P. Cardiovascular, endocrine and renal actions of acute potassium channel activation by BRL34915 in man. Cardiovascular Drugs and Therapy 1(3): 241, 1987

    Google Scholar 

  • Goldberg MR. Clinical pharmacology of pinacidil, a prototype for drugs which affect potassium channels. Journal of Cardiovascular Pharmacology 12 (Suppl. 2): 541–549, 1988

    Article  Google Scholar 

  • Goldberg MR, Rockhold RW. Beneficial effects of pinacidil on plasma lipids. Journal of Hypertension 4 (Suppl. 5): S575, 1986

    Article  Google Scholar 

  • Gosling JA, Gilpin SA, Dixon JS, Gilpin CJ. Decrease in autonomie innervation of human detrusor muscle in outflow obstruction. Journal of Urology 136: 501–504, 1986

    PubMed  CAS  Google Scholar 

  • Hamilton TC, Weston AH. Cromakalim, nicorandil and pinacidil: novel drugs which open smooth muscle potassium channels. General Pharmacology 20: 1–9, 1989

    PubMed  CAS  Google Scholar 

  • Harder DR, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. Journal of Clinical Investigation 80: 875–880, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hayata N, Araki H, Nakamura M. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double blind study. American Heart Journal 112(2): 1245–1250, 1986

    Article  PubMed  CAS  Google Scholar 

  • Heal MR. Treatment of impotence. Postgraduate Update Feb. 1: 235–242, 1989

    Google Scholar 

  • Holmquist F, Andersson K-E, Fovaeus M, Hedlund H. K+ channel openers for relaxation of penile erectile tissue. Proceedings of the American Urological Association, p. 148, October 2–5, 1988

  • Holzmann S. Cyclic GMP as a possible mediator of coronary arterial relaxation by nicorandil (SG-75). Journal of Cardiovascular Pharmacology 5: 364–379, 1983

    Article  PubMed  CAS  Google Scholar 

  • Kassel NF, Sasaki T, Colohan A, Nazure G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562–572, 1985

    Article  Google Scholar 

  • Kinoshita M, Nishikawa S, Sawamura M, Yamaguchi S, Mitsunami K, et al. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris. American Journal of Cardiology 58: 733–738, 1986

    Article  PubMed  CAS  Google Scholar 

  • Kishida H, Murao S. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris. Clinical Pharmacology and Therapeutics 42: 166–174, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kreye VAW, Gross F. Drugs acting on arteriolar smooth muscle (vasodilator drugs). In Gross F (Ed.) Antihypertensive agents, pp. 397–476, Springer Verlag, Heidelberg, 1977

    Google Scholar 

  • Malmgren A, Andersson K-E, Andersson PO, Fovaeus M, Sjogren C. Effects of cromakalim (BRL34915) and pinacidil on normal and hypertrophied rat detrusor in vitro. Journal of Urology 143: 828–834, 1990

    PubMed  CAS  Google Scholar 

  • Malmgren A, Andersson K-E, Sjogren C, Andersson PO. Effects of pinacidil and cromakalim (BRL34915) on bladder function in rats with detrusor instability. Journal of Urology 142: 1134–1138, 1989

    PubMed  CAS  Google Scholar 

  • Newgreen DT, Bray KM, McHarg AD, Weston AH, Duty S, et al. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. British Journal of Pharmacology 100(3): 101–109, 1990

    Article  Google Scholar 

  • Nguyen PV, Davis A, Tasker TCG, Leenen FHH. Effects of BRL34915 on pressor and chronotropic responses to iv nor-epinephrine, angiotensin II and isoproterenol in normal man. Cardiovascular Drugs and Therapy 1(3): 270, 1987

    Google Scholar 

  • Nielsen-Kudsk JE, Mellemkjaer S, Siggaard C, Nielsen CB. Effects of pinacidil on guinea-pig airway smooth muscle contracted by asthma mediators. European Journal of Pharmacology 157: 221–226, 1988

    Article  PubMed  CAS  Google Scholar 

  • Noble D. The surprising heart: a review of recent progress in cardiac electrophysiology. Journal of Physiology 353: 156–159, 1984

    Google Scholar 

  • North RA. Drug receptors and the inhibition of nerve cells. British Journal of Pharmacology 98: 13–28, 1989

    Article  PubMed  CAS  Google Scholar 

  • Preuss KC, Gross GJ, Brooks HL, Warltier DC. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog. Journal of Cardiovascular Pharmacology 7: 709–714, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rudy B. Diversity and ubiquity of K channels. Neuroscience 25: 729–749, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sakai K, Nakano H, Nagano H, Uchida Y. Nicorandil. In Scriabine A (Ed.) New drugs annual: cardiovascular drugs, pp. 227–242, Raven Press, New York, 1983

    Google Scholar 

  • Sakai K, Shiraka Y, Nabuta H. Cardiovascular effect of a new coronary vasodilator 2-Nicotinamide ethyl nitrate (SG-75): comparison with nitroglycerin and diltiazem. Journal of Cardiovascular Pharmacology 3: 139–150, 1981

    Article  PubMed  CAS  Google Scholar 

  • Shibata S, Satake N. Differential inhibitory effects of nicorandil, a new antiangina agent, on the contractile responses to alpha-1 and alpha-2 adrenoceptor agonists in isolated rabbit renal and femoral arteries. Pharmacology 34: 213–224, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sibley GNA. An experimental model of detrusor instability in the obstructed pig. British Journal of Urology 57: 292–298, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sibley GNA, Brading AF, Smith JC. The aetiology of detrusor instability in patients with prostatic obstruction. Proceedings of the International Continence Society, p. 481, 14th Meeting, Innsbruck, September 13–15, 1984

  • Singer DRJ, Markandu ND, Miller MA, Sugden AL, MacGregor GA. Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with cromakalim (BRL34915). Proceedings of the 4th European Meeting on Hypertension. Journal of Hypertension 7: 294–295, 1989

    Google Scholar 

  • Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, et al. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245: 177–180, 1989

    Article  PubMed  CAS  Google Scholar 

  • Vandenburg MJ, Arr-Woodward M, Stewart-Long P, Tasker T, Dews IM, et al. Potassium channel activators: antihypertensive activity and adverse effect profile of BRL34915. Journal of Hypertension 5 (Suppl. 5): 5193–5195, 1987

    Google Scholar 

  • Webb DJ, Benjamin N, Vallance P. The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers. British Journal of Clinical Pharmacology 27: 757–761, 1989

    Article  PubMed  CAS  Google Scholar 

  • Weston AH. Smooth muscle potassium channel openers; their pharmacology and clinical potential. Pflügers Archiv European Journal of Physiology 414 (Suppl. 1): S99–S105, 1989

    Article  PubMed  Google Scholar 

  • Williams AJ, Hopkirk A, Lavender E, Vyse I, Chiew VF, et al. Inhibition of nocturnal asthma by relaxation of airway smooth muscle with a potassium channel activator. Annual Reviews of Respiratory Disease 139(2): A140, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Smooth Muscle Research Group, Department of Physiological Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, England

    Susan Duty & Arthur H. Weston (Prof)

Authors
  1. Susan Duty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur H. Weston
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duty, S., Weston, A.H. Potassium Channel Openers. Drugs 40, 785–791 (1990). https://doi.org/10.2165/00003495-199040060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199040060-00002

Keywords

Search

Navigation